4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-002171
President and CEO sold 105,693 shares at $2.71 ($286,428)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil President and CEO | 2021-01-04 | Sale | −105,693 | $2.71 | $286,428 | 1,799,280 | D |
| Open-market sales · 105,693 sh · avg $2.71 · $286,428 | |||||||
Loading xslF345X03/doc4.xml…